Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$834K Buy
17,301
+10,301
+147% +$480K 0.01% 389
2025
Q4
$339K Buy
+7,000
New +$347K 0.01% 610
2024
Q1
Sell
-5,918
Closed -$294K 477
2023
Q4
$294K Buy
5,918
+726
+14% +$35.5K ﹤0.01% 240
2023
Q3
$278K Buy
5,192
+354
+7% +$18.9K 0.01% 276
2023
Q2
$261K Sell
4,838
-1,181
-20% -$63.5K 0.01% 277
2023
Q1
$328K Buy
+6,019
New +$293K 0.01% 246
2020
Q3
Sell
-14,900
Closed -$761K 215
2020
Q2
$761K Buy
+14,900
New +$724K 0.04% 98
2013
Q4
Sell
-34,027
Closed -$1.77M 249
2013
Q3
$1.77M Buy
+34,027
New +$1.73M 0.14% 41

Other funds holding SNY

DRW Securities's SNY Position: Q1 2026 in Review

DRW Securities increased its Sanofi (SNY) stake by 147% in Q1 2026, buying an estimated $480K and bringing the position to 17,301 shares worth $834K. The position accounts for 0.01% of the portfolio, ranked #389.

DRW Securities first reported a position in SNY in Q3 2013 and has held it in 8 quarters since. The position peaked at $1.77M in Q3 2013. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • DRW Securities held 17,301 shares of Sanofi worth $834K as of Q1 2026.
  • DRW Securities bought 10,301 Sanofi shares in Q1 2026, an estimated $480K.
  • Sanofi made up 0.01% of DRW Securities's portfolio in Q1 2026, its #389 holding.
  • DRW Securities first reported a position in Sanofi in Q3 2013 and has held it in 8 quarters since.
  • DRW Securities's Sanofi position peaked at $1.77M in Q3 2013.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.